Search Clinical Trials

The purpose of this study is to learn more about an investigational drug called DS-1471a. DS-1471a is an investigational drug that is not approved for your disease by health authorities, such as the U.S. Food and Drug Administration (FDA). It is being studied to see if it is safe and if your disease or medical condition improves while taking it.

DAIICHI-SANKYO-DS1471-079

Cancer, Lung, Gastrointestinal Cancers, Early Phase/Multiple Disease Site Cancers, Head and Neck Cancers, Thoracic Cancers

The purpose of this study is to learn more about an investigational drug called DS-3939a. DS-3939a is an investigational drug that is not approved for your disease. It is being studied to see if it is safe and if your disease or medical condition improves while taking it.

DAIICHI-SANKYO-DS3939-077

Cancer, Kidney, Skin Cancers, Stomach, Uterine, Lung, Other Urologic, Head and Neck Cancers, Esophagus, Thoracic Cancers, Ovary, Other Gastrointestinal, Sarcoma, Gastrointestinal Cancers, Prostate, Prostate and Urologic Cancers, Cervix, Gynecologic Cancers, Early Phase/Multiple Disease Site Cancers, Breast Cancers

Study of ifinatamab deruxtecan in subjects with relapsed small cell lung cancer

DAIICHI-DS7300-188

Cancer, Lung, Thoracic Cancers

A phase I/II study of VLS-1488 (an oral KIF18A inhibitor) in subjects with advanced cancer

VOLASTRA-VLS-1488-2201

Cancer, Prostate and Urologic Cancers, Early Phase/Multiple Disease Site Cancers, Colorectal, Gastrointestinal Cancers, Lung, Thoracic Cancers, Head and Neck Cancers, Gynecologic Cancers, Breast Cancers

Comparing impact of treatment before or after surgery in patients with resectable NSCLC

ALLIANCE-A082304-PROSPECT-LUNG

Cancer, Lung, Thoracic Cancers

To assess the safety, tolerability, dose-limiting toxicities (DLTs), and determine the maximum tolerated dose of INBRX-106 as a single agent administered as an intravenous infusion and in combination with pembrolizumab.

INHIBRX-PH1-INBRX-106

Cancer, Other Gastrointestinal, Gynecologic Cancers, Kidney, Melanoma, Skin, Skin Cancers, Prostate and Urologic Cancers, Head and Neck Cancers, Gastrointestinal Cancers, Thoracic Cancers, Early Phase/Multiple Disease Site Cancers

The study is researching an investigational drug called REGN7075 by itself and in combination
with cemiplimab with or without chemotherapy.

REGENERON-R7075-ONC-2009

Cancer, Early Phase/Multiple Disease Site Cancers, Larynx, Gastrointestinal Cancers, Lip, Oral Cavity and Pharynx, Thoracic Cancers, Breast Cancers, Head and Neck Cancers, Skin Cancers

Study of of Zipalertinib in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

TAIHO-TAS6417-201

Cancer, Thoracic Cancers

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

NRG-BN013

Cancer, Other Skin, Bladder, Colorectal, Cervix, Other Gynecologic, Breast Cancers, Esophagus, Prostate, Larynx, Other Gastrointestinal, Esophagus, Gynecologic Cancers, Other Respiratory, Melanoma, Skin, Prostate and Urologic Cancers, Pancreas/Liver, Eye/Orbital Cancers, Thoracic Cancers, Lip, Oral Cavity and Pharynx, Head and Neck Cancers, Gastrointestinal Cancers, Endocrine Cancers, Skin Cancers, Brain and Spine Cancers

IIT-GEORGE-I-PREDICT

IIT-GEORGE-I-PREDICT

Cancer, Colorectal, Gynecologic Cancers, Esophagus, Other Urologic, Head and Neck Cancers, Early Phase/Multiple Disease Site Cancers, Esophagus, Skin Cancers, Stomach, Prostate and Urologic Cancers, Pancreas/Liver, Breast Cancers, Other Gastrointestinal, Sarcoma, Gastrointestinal Cancers, Lung, Thoracic Cancers